Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Autolomous logo — Pragmatic digital solutions for Cell and Gene Therapy Manufa...

Autolomous

Pragmatic digital solutions for Cell and Gene Therapy Manufacturing

Founded 2019 United Kingdom London, United Kingdom 38 employees Grant Biotechnology, Health Care +3

General Information

Company Name Autolomous
Founded Year 2019
Location United Kingdom London, United Kingdom
Employees 38
Industries Biotechnology, Health Care, Information Technology +2
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Autolomous. To contact Autolomous, visit autolomous.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Autolomous compare?

A PDF of Autolomous and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Autolomous soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Autolomous

Autolomous is a UK-based startup focused on providing digital solutions for Cell and Gene Therapy Manufacturing. Founded in 2019 by experts in the field, the company aims to offer scalable and agile software solutions for the Cell and Gene Therapy sector. Their flagship product, AutoloMATE-solution platform, encompasses various software solutions including electronic Batch Manufacturing Records (eBMR), patient blood collection scheduling, traceability enhancement, regulatory compliance support, and drug product release acceleration. The company's focus on automation and risk reduction aligns with the industry's need for precision and efficiency. Their recent grant investment from Innovate UK on 12 June 2023 validates their potential for growth and innovation in the biotechnology, healthcare, information technology, manufacturing, and pharmaceutical sectors. Autolomous offers an exciting opportunity for forward-thinking individuals to contribute to a meaningful and value-driven company. Their pragmatic approach to digital solutions positions them as a promising entity in the evolving landscape of Cell and Gene Therapy.

Business keywords: advanced therapy manufacturing, biotech industry, collaborative approach, science and health, custom IT solutions, innovative technology, academic institutions, NHS, value-added, pioneering, expertise

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
Innovate UK
Innovate UK
12 Jun 2023

Autolomous Alternatives & Competitors

View All Alternatives
Autolomous vs
Alvimedica
Alvimedica Turkey

A company focused on developing innovative solutions for the healthcare sector.

149 employees
Health Care, Hospitality
Compare Autolomous vs Alvimedica
Autolomous vs
Cambridge Cognition
Cambridge Cognition United Kingdom

Your all-in-one platform for cognitive data.

Grant
68 employees
Biotechnology, Health Care
Compare Autolomous vs Cambridge Cognition
Autolomous vs
VintaBio
VintaBio United States

VintaBio delivers customized process development and GMP manufacturing service for cell and gene the...

Venture round
31 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Autolomous

Pragmatic digital solutions for Cell and Gene Therapy Manufacturing
Autolomous was founded in 2019.
Autolomous is headquartered in London, United Kingdom.
Autolomous operates in Biotechnology, Health Care, Information Technology, Manufacturing and Pharmaceutical. Its work centres on advanced therapy manufacturing, biotech industry, collaborative approach and science and health.
Autolomous has approximately 38 employees.
Autolomous has completed 1 funding round. The latest funding stage is Grant.
Top alternatives and competitors to Autolomous include Alvimedica, Cambridge Cognition, VintaBio, Dianox, MTC - Manufacturing Technology Centre. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Autolomous and Alvimedica are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Autolomous, https://bouncewatch.com/company/autolomous, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes